Post-approval studies (Phase 4)Study completedNCT00347503
What this trial is testing
Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients
Who this might be right for
Cataract
Innovative Medical
Showing 20 of 299 results